QuidelOrtho (QDEL) stock
QDEL's Quality Score rose 1 point on Mon, Nov 2, to -4.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Key facts on QDEL
| Holding it back | Sales down 16% |
| Latest filing | 8-K, Sep 23 |
QDEL in the news
TodayNo story names it yet.
QDEL catalysts
After its last 4 reports it closed -17.7% on average, higher 0 of 4 times.
Why QDEL scores -4
Poorfor quality, not price, 4 of 14 chart checks firingWhat the Quality Score means
- +4Chart checks 4 of 14 firing right now, one point each
- −3Long-term trend below a falling 200-day average, down over one year, down over two years
- Profit subtracts
- Growth subtracts
- Volatility subtracts
- Cash flow subtracts
Here is what Pro members see.
- Prices refresh every 2.5 seconds during market hours.
- Optional alerts by push, email, or the bell.
- Add it to your Home Screen and it opens like an app.
QDEL has 4 of 14 chart checks firing
QDEL RSI today: 57.3, above its 50-day, below its 200-day
- RSI 1457.3
- MACD (12, 26, 9)Above signal
- 50-day average$12.74
- 200-day average$16.15
- 50/200 crossDeath cross
- ADX 1422.3
- Support$13.21
- Resistance$14.65
- 52-week high$35.58
- 52-week low$9.92
- Chart patternTriangle
- Bollinger Bands (20, 2)Inside
- Volume1.3x
The deep dive on QDEL
- What it does and how it makes money
- Where it standsCash flow statements to Jun 28, 2026, filed Aug 7, 2026
- What changed in its filingsSEC filing · Aug 7, 2026
- Who holds and trades it
How QDEL ranks in Pharma
QDEL is #78 of 92 by Quality Score.
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 78 |
When does QDEL report earnings, and what happens after?
Reports Tue Nov 3, after the close (tomorrow). Confirmed.
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
What QDEL reported on Aug 6, 2026
The quarter
The figures are not read from the release yet.
“Growth was driven by continued strength across the core business and partially offset by slower sales in China, which the Company believes is primarily related to recently announced changes to In Vitro Diagnostics pricing.”
Where the sales came from
QDEL's results filing gives no sales by line in a table we read.
The outlook
No outlook figures read from this release.
The numbers
- $944M
- today
- $2.7B
- down 2.5% on the year
- -$211M
- last 12 months
Sales fell 5.8% a year over 3 years, fiscal 2022 to 2025.
Its share count grew 5.7% a year over 3 years.
| Reported | Gap | Reaction | 5 sessions |
|---|---|---|---|
| Aug 6, 2026 | -22.4% | -24.7% | -7.5% |
| May 5, 2026 | -4.3% | -6.0% | -4.6% |
| Feb 11, 2026 | -7.4% | -17.6% | -18.0% |
QDEL sales and profit by year
Sales fell every year from 2022 to 2025, to $2.7B. It made a profit in one of the four years.
Insiders trading QDEL
QDEL trades by Congress and the executive branch
4 trades disclosed in the last six months. The newest:
QDEL's officers and directors
Officers and directors with a Form 4 in the last 12 months.
Which ETFs hold QDEL?
In ETFs: QDEL is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.
About QuidelOrtho
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.
QDEL's score card
Pro members see every line of every stock's score.
- What would turn QDEL's score around: 8 things
- 2 more filings explained, a plain line each
- Real-time prices, no delay
Straight Answers
Is QDEL a good stock to buy? What its Quality Score says
QDEL scores -4 today, which Breakaway calls Poor. It is #78 of 92 in Pharma by Quality Score, with 4 of 14 chart checks firing. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
What is QDEL's Quality Score?
QDEL scores -4 today, which Breakaway calls Poor (below zero). That is #78 of 92 in Pharma by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind QDEL's -4.
When does QDEL report earnings?
Reports Tue Nov 3, after the close, a date the company confirmed. QDEL closed higher after 0 of its last 4 reports. Past behavior, not a forecast.
Are the prices delayed?
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.